IP Library Granted Patent US 7,375,228
Granted Patent B2
US 7,375,228 · App. 10/803,580 · Granted May 20, 2008

Histone deacetylase inhibitors

Assignee: Takeda San Diego, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,375,228
App. No.
10/803,580
Granted
May 20, 2008
Kind
B2
Abstract

Compounds that may be used to inhibit histone deacetylase having the formula Z-Q-L-M or Z-L-M wherein M is a substituent capable of complexing with a deacetylase catalytic site and/or a metal ion; L is a substituent providing between 0-10 atoms separation between the M substituent and the remainder of the compound; and Z and Q are as defined herein.

Claims (79)

1. A compound consists of a formula selected from the group consisting of

wherein

R 2 , R 3 , R 4 , and R 5 are each independently selected from the group consisting of hydrogen, halo, alkyl, alkoxy, aryl, heteroaryl, aminosulfonyl, alkylsulfonyl, arylsulfonyl, heteroarylsulfonyl, aryloxy, heteroaryloxy, arylalkyl, heteroarylalkyl, amino, thio, cyano, nitro, and a carbonyl group, each substituted or unsubstituted;

R 14 is selected from the group consisting of hydrogen, halo, alkyl, alkoxy, aryl, heteroaryl, aminosulfonyl, alkylsulfonyl, arylsulfonyl, heteroarylsulfonyl, aryloxy, heteroaryloxy, arylalkyl, heteroarylalkyl, amino, a substituted or unsubstituted —C(O)C 1-6 alkyl, acetyl and BOC;

M is selected from the group consisting of trifluoroacetyl (—C(O)—CF 3 ), —NH—P(O)OH—CH 3 , sulfonamides (—SO 2 NH 2 ), hydroxysulfonamides (—SO 2 NHOH), thiols(—SH), and carbonyl groups having the formula —C(O)—R 13 wherein R 13 is hydroxylamino, hydroxyl, amino, alkylamino, and an alkoxy group, each substituted or unsubstituted; and

L is a substituent providing between 2-10 atoms separation between the M substituent and the remainder of the compound, wherein the 2-10 atoms are all carbon atoms.

2. The compound according to claim 1 , wherein the compound consists of a formula selected from the group consisting of

3. The compound according to claim 1 , wherein the compound consists of a formula selected from the group consisting of

4. The compound according to claim 1 , wherein R 14 is hydrogen.

5. The compound according to claim 1 , wherein R 14 is a substituted or unsubstituted C 1-6 alkyl.

6. The compound according to claim 1 , wherein R 14 is a substituted or unsubstituted —C(O)C 1-6 alkyl.

7. The compound according to claim 1 , wherein R 14 is selected from the group consisting of H, methyl, ethyl, propyl, isopropyl, butyl, acetyl, and BOC.

8. The compound according to claim 1 , wherein at least one of R 2 , R 3 , R 4 , or R 5 is fluoro.

9. The compound according to claim 1 , wherein M is selected from the group consisting of:

10. The compound according to claim 1 , wherein M is a hydroxamic acid moiety.

11. The compound according to claim 1 , wherein -L-M is

12. A compound of a formula selected from the group consisting of

wherein

R 2 , R 3 , R 4 , and R 5 are each independently selected from the group consisting of hydrogen, halo, alkyl, alkoxy, aryl, heteroaryl, cyano and nitro, each substituted or unsubstituted;

R 14 is selected from the group consisting of hydrogen, halo, alkyl, alkoxy, aryl, heteroaryl, aminosulfonyl, alkylsulfonyl, arylsulfonyl, heteroarylsulfonyl, aryloxy, heteroaryloxy, arylalkyl, heteroarylalkyl, amino, a substituted or unsubstituted —C(O)C 1-6 alkyl, acetyl and BOC;

M is selected from the group consisting of trifluoroacetyl (—C(O)—CF 3 ), —NH—P(O)OH—CH 3 , sulfonamides (—SO 2 NH 2 ), hydroxysulfonamides (—SO 2 NHOH), thiols(—SH), and carbonyl groups having the formula —C(O)—R 13 wherein R 13 is hydroxylamino, hydroxyl, amino, alkylamino, and an alkoxy group, each substituted or unsubstituted; and

L is a substituent providing between 2-10 atoms separation between the M substituent and the remainder of the compound, wherein the 2-10 atoms are all carbon atoms.

13. The compound according to claim 12 , wherein the compound comprises a formula selected from the group consisting of

14. The compound according to claim 12 , wherein the compound consists of a formula selected from the group consisting of

15. The compound according to claim 12 , wherein R 14 is hydrogen.

16. The compound according to claim 12 , wherein R 14 is a substituted or unsubstituted C 1-6 alkyl.

17. The compound according to claim 12 , wherein R 14 is a substituted or unsubstituted —C(O)C 1-6 alkyl.

18. The compound according to claim 12 , wherein R 14 is selected from the group consisting of H, methyl, ethyl, propyl, isopropyl, butyl, acetyl, and BOC.

19. The compound according to claim 12 , wherein at least one of R 2 , R 3 , R 4 , or R 5 is fluoro.

20. The compound according to claim 12 , wherein M is selected from the group consisting of:

21. The compound according to claim 12 , wherein M is a hydroxamic acid moiety.

22. The compound according to claim 12 , wherein -L-M is

23. A compound of a formula selected from the group consisting of

wherein

R 2 , R 3 , R 4 , and R 5 are each independently selected from the group consisting of hydrogen, halo, (C 1-10 )alkyl, (C 1-10 )alkoxy, (C 5-12 )aryl, (C 5-12 )heteroaryl, cyano, and nitro, each substituted or unsubstituted;

R 14 is selected from the group consisting of hydrogen, halo, alkyl, alkoxy, aryl, heteroaryl, aminosulfonyl, alkylsulfonyl, arylsulfonyl, heteroarylsulfonyl, aryloxy, heteroaryloxy, arylalkyl, heteroarylalkyl, amino, a substituted or unsubstituted —C(O)C 1-6 alkyl, acetyl and BOC;

M is selected from the group consisting of

and

L is selected from the group consisting of (E) isomer of —CH═CH—, (Z) isomer or —CH═CH—, and mixture of (E) and (Z) isomers —CH═CH—.

24. The compound according to claim 23 , wherein the compound consists of a formula selected from the group consisting of

25. The compound according to claim 23 , wherein the compound consists of a formula selected from the group consisting of

26. The compound according to claim 23 , wherein R 14 is hydrogen.

27. The compound according to claim 23 , wherein R 14 is a substituted or unsubstituted C 1-6 alkyl.

28. The compound according to claim 23 , wherein R 14 is a substituted or unsubstituted —C(O)C 1-6 alkyl.

29. The compound according to claim 23 , wherein R 14 is selected from the group consisting of H, methyl, ethyl, propyl, isopropyl, butyl, acetyl, and BOC.

30. The compound according to claim 23 , wherein at least one of R 2 , R 3 , R 4 , or R 5 is fluoro.

31. The compound according to claim 23 , wherein M is a hydroxamic acid moiety.

32. The compound according to claim 23 , wherein -L-M is

33. The compound according to claim 1 , wherein M is

34. The compound according to claim 1 , wherein M is

35. The compound according to claim 1 , wherein M is

36. The compound according to claim 1 , wherein M is

37. The compound according to claim 1 , wherein M is

38. The compound according to claim 1 , wherein M is

39. The compound according to claim 1 , wherein M is

40. The compound according to claim 1 , wherein M is

41. The compound according to claim 1 , wherein M is

42. The compound according to claim 1 , wherein M is

43. The compound according to claim 12 , wherein M is

44. The compound according to claim 12 , wherein M is

45. The compound according to claim 12 , wherein M is

46. The compound according to claim 12 , wherein M is

47. The compound according to claim 12 , wherein M is

48. The compound according to claim 12 , wherein M is

49. The compound according to claim 12 , wherein M is

50. The compound according to claim 12 , wherein M is

51. The compound according to claim 12 , wherein M is

52. The compound according to claim 12 , wherein M is

53. The compound according to claim 12 , wherein M is

54. The compound according to claim 23 , wherein M is

55. The compound according to claim 23 , wherein M is

56. The compound according to claim 23 , wherein M is

57. The compound according to claim 23 , wherein M is

58. The compound according to claim 23 , wherein M is

59. The compound according to claim 23 , wherein M is

60. The compound according to claim 23 , wherein M is

61. The compound according to claim 23 , wherein M is

62. The compound according to claim 1 , wherein -L-M is

63. The compound according to claim 12 , wherein -L-M is

Assignments (2)
CHANGE OF NAME Recorded Aug 16, 2006
From: SYRX, INC.
To: TAKEDA SAN DIEGO, INC.
Reel/Frame 018132/0496 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2004
From: BRESSI, JEROME C.; BROWN, JASON W.; CAO, SHELDON X.; GANGLOFF, ANTHONY R.; JENNINGS, ANDREW J.; STAFFORD, JEFFREY A.; VU, PHONG H.; XIAO, XIAO-YI
To: SYRRX, INC.
Reel/Frame 015458/0449 →
Continuity (3)
Provisional Application 6053120300 · Dec 19, 2003
Provisional Application 6045543700 · Mar 17, 2003
Related Publication 20050137232A1 · Jun 23, 2005